Observation On The Therapeutic Effect Of Qi-Enriching And Surface-strengthening Therapy On Cough Variant Asthma Of Lung-spleen Deficiency Type

ObjectiveThrough comprehensive analysis and evaluation of Asthma Control Test(ACT)score,pulmonary function index and TCM syndrome score,this study studied the law of benefiting Qi and fixing defense combined with self-blood acupoint injection in the treatment of cough variant asthma(pulmonary and spleen-qi deficiency type).MethodsThis study is a prospective randomized controlled trial.Sixty cough variant asthma patients with pulmonary-spleen deficiency were selected from the inpatients and outpatients of respiratory department of Guangzhou Hospital of Traditional Chinese Medicine.According to the random number table,the patients were divided into treatment group and control group with 36 cases each.The treatment group was treated with salmeterol and fluticasone powder inhalation for patients with cough variant asthma.The control group was treated with the law of benefiting qi and fixing defense and oral Chinese medicine on the basis of the treatment group.The treatment course of both groups was 2 weeks.The data of adverse reaction history,asthma control test score before and after treatment,pulmonary function index and TCM syndrome score were collected during the treatment period.The collected events and data were analyzed and the conclusions were drawn.ResultsThe total effective rate was 91.18%in the treatment group and 82.35%in the control group.There was no significant difference in the clinical efficacy between the two groups after treatment(P>0.05).However,in the symptom score,the two groups can effectively improve the symptoms of cough,shortness of breath,poor fatigue and other symptoms,and compared with the control group.The improvement degree of the treatment group was more obvious(P<0.05),so the clinical effect of the treatment group was better than that of the control group.The comparison of ACT scores showed that the scores of the two groups increased significantly after treatment(P<0.05).Compared with the control group,the improvement of the treatment group was more obvious(P<0.05).It proved that both groups of treatment schemes could effectively control the daily onset symptoms of CVA patients in ACT scores,and the treatment group could improve the control of water better than the control group.Ping.Relevant indexes of pulmonary function:After treatment,PEF values of CVA patients were significantly increased in both groups(P<0.05).Compared with the control group,the treatment group increased more significantly than the control group(P<0.05);at the level of FEV,,there were significant differences between the two groups before and after treatment(P<0.05),but there was no difference between the two groups after treatment.It was proved that both groups could improve PEF level and airway obstruction,but the curative effect of treatment group was better(P<0.05),and FEV1 could be improved.In this study,no adverse reactions occurred during the implementation process,which proves that it is safe to treat CVA patients(pulmonary and spleen-qi deficiency type)with the method of Invigorating qi and strengthening qi.ConclusionThe combination of internal and external therapy with Salmeterol and fluticasone powder inhalation(50 ug/250 ug)under the method of benefiting qi and fixing defense can effectively alleviate clinical symptoms and improve airway obstruction in patients with CVA(lung-spleen-qi deficiency type).The curative effect is better than that of Salmeterol and fluticasone powder inhalation(50 ug/250 ug)alone.